SHMT2 and diffuse large B-cell lymphoma: Selective SHMT2 inhibitors could be useful for the treatment of malignancies like diffuse large B-cell lymphoma where glycine uptake is impaired and cancer cells are solemnly depending on mitochondrial 1C metabolism for glycine production.